Volume 148, Issue 6, Pages (December 2015)

Slides:



Advertisements
Similar presentations
Volume 32, Issue 1, Pages (July 1957)
Advertisements

Volume 34, Issue 2, Pages (August 1958)
Noninvasive Nasal Mask Ventilation for Acute Respiratory Failure
Atypical Pulmonary Diseases Associated with AIDS
Tell-tale Telangiectasias
Volume 104, Issue 2, Pages (August 1993)
Colloquium on Therapy of Right Heart Failure
A Preliminary Study of Elevated Alkaline Phosphatase and Cathepsin in Bronchial Aspirates of Patients with Lung Cancer and Bronchitis  S.H. Kühn, M.Sc.,
Volume 77, Issue 5, Pages (May 1980)
Volume 148, Issue 6, Pages (December 2015)
When to Be Rash About a Fever and Headache
Effects of Medroxyprogesterone Acetate in Obstructive Sleep Apnea
WEN Y. YUE, M.D., F.C.C.P., SUMNER S. COHEN, M.D., F.C.C.P. 
Causes of Death in Carcinoma of the Lung in a Large Public Hospital
Volume 133, Issue 4, Pages (April 2008)
Volume 136, Issue 6, Pages (December 2009)
Volume 105, Issue 1, Pages (January 1994)
Volume 137, Issue 6, Pages (June 2010)
Natural Disasters and Nontuberculous Mycobacteria
Hyperbaric Oxygenation in Cardiac and Pulmonary Disease
Volume 121, Issue 4, Pages (April 2002)
Air Pollution and Chest Disease
Navin K. Jain, MD, Thiam H. Lie, MD, FCCP  CHEST 
Volume 123, Issue 2, Pages (February 2003)
Clinical and Personality Profiles and Survival in Patients With COPD
Fever, Skin Eruption, Low Serum Gammaglobulin in a Child with Leukemia
Effects of Prostaglandin E1 on Oxygen Delivery and Consumption in Patients with the Adult Respiratory Distress Syndrome  Henry J. Silverman, M.D., F.C.C.P. 
Oxygen Therapy Titrated to Raise Mixed Venous Oxygen Content in COPD
Volume 148, Issue 5, Pages (November 2015)
Frank W. Ewald, MD, FCCP, Albert H. Scherff, MD  CHEST 
Volume 142, Issue 1, Pages (July 2012)
COUNTERPOINT: Is the Apnea-Hypopnea Index the Best Way to Quantify the Severity of Sleep-Disordered Breathing? No  Naresh M. Punjabi, MD, PhD, FCCP  CHEST 
Breakage of Forceps Valve Cover and Its Introduction into a Patient
Volume 104, Issue 3, Pages (September 1993)
Arterial Line or Cuff BP?
Has the 6-Min Walk Distance Run Its Course?
Volume 79, Issue 2, Pages (February 1981)
Handedness and Sleep Apnea
Counterpoint: Adherence to Early Goal-Directed Therapy
Airway Stenting for Patients With Benign Airway Disease and the Food and Drug Administration Advisory  Lund Mark E. , MD, FCCP, Force Seth , MD, FCCP 
Decortication after 35 Years
PEEP, Auto-PEEP, and Waterfalls
Sundeep Salvi, MD, DNB, PhD, FCCP, Peter J. Barnes, DM, FCCP  CHEST 
Volume 104, Issue 1, Pages 1-2 (July 1993)
Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1
Detecting Antimycobacterial Antibodies
Imaging for the Management of Community-Acquired Pneumonia
Spread the Word About CHEST in 2015
Translational Behavioral Research in Respiratory Medicine
Volume 149, Issue 6, Pages (June 2016)
Volume 138, Issue 4, Pages (October 2010)
Evolution in Reimbursement for Sleep Studies and Sleep Centers
Bedside Calibration Of Pulmonary Artery Catheters
Invasive Pulmonary Aspergillosis
Volume 146, Issue 6, Pages (December 2014)
Pulmonary Manifestations in a Case of Multiple Myeloma
Do CIs Give You Confidence?
Effects of Beta-Adrenergic Agents on Hypokalemia
A Single Nasal Prong for Continuous Oxygen Therapy
Myocardial Sarcoidosis Unresponsive to Steroids
Theophylline Dose-dumping
Volume 146, Issue 4, Pages (October 2014)
Interaction of Rifampin and Glyburide
Volume 42, Issue 2, Pages (August 1962)
Natural Disasters and Nontuberculous Mycobacteria
Thoracic Surgery Survey on Lung Cancer Management
Digitalis and Angina Pectoris
Arterial Line or Cuff BP?
New Members of the Editorial Board
Rebuttal From Dr Kollef
Presentation transcript:

Volume 148, Issue 6, Pages 1447-1453 (December 2015) Ordering of the Serum Angiotensin-Converting Enzyme Test in Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy  Matthew D. Krasowski, MD, PhD, Johanna Savage, MD, Alexandra Ehlers, BS, Jon Maakestad, BS, Gregory A. Schmidt, MD, FCCP, Sonia La'ulu, BS, Natalie N. Rasmussen, BS, Frederick G. Strathmann, PhD, Jonathan R. Genzen, MD, PhD  CHEST  Volume 148, Issue 6, Pages 1447-1453 (December 2015) DOI: 10.1378/chest.15-1061 Copyright © 2015 The American College of Chest Physicians Terms and Conditions

Figure 1 ACE levels in patients at University of Iowa. A, ACE activities in patients receiving an ACE inhibitor (n = 108) vs not receiving an ACE inhibitor (n = 1,184). P «i .001 between the two groups by Mann-Whitney U test. B, Distribution of ACE activities indicating percentage of patients receiving an ACE inhibitor within each category. ACE = angiotensin-converting enzyme. CHEST 2015 148, 1447-1453DOI: (10.1378/chest.15-1061) Copyright © 2015 The American College of Chest Physicians Terms and Conditions

Figure 2 Distribution of patient results from 70,000 consecutive ACE assays at the national reference laboratory. A, Female results. B, Male results. Data are displayed in 2-U/L bin increments. Results below the assay analytical measurement range (> 5 U/L) are shown in the leftmost, isolated vertical bar in each graph; x-axes are cropped at 100 U/L. See Figure 1 legend for expansion of abbreviation. CHEST 2015 148, 1447-1453DOI: (10.1378/chest.15-1061) Copyright © 2015 The American College of Chest Physicians Terms and Conditions

Figure 3 Concentration-response relationships of three common ACE inhibitors on ACE assay activity. Inhibition of ACE activity by increasing concentrations of lisinopril (⋄), enalaprilat (•), and captopril (□) is shown. Symbol and error bars indicate mean ± SD. The ACE assay is the one used by ARUP Laboratories. Laboratories Figure 1 legend for expansion of abbreviation. CHEST 2015 148, 1447-1453DOI: (10.1378/chest.15-1061) Copyright © 2015 The American College of Chest Physicians Terms and Conditions